Skip to Content
COVID-19 News | UPMC
COVID-19 News | UPMC

COVID-19 News From UPMC

At UPMC, we are doing everything we can to keep our communities safe from COVID-19. This page will provide the latest news and information about our response to COVID-19, including important UPMC announcements and updates on COVID-19 vaccines, treatments, and more.

UPMC Press Briefings

January 31, 2022

UPMC clinical leaders provide an update on the impact of the Omicron variant in our communities. They also share more information about Evusheld — the first-ever monoclonal antibody authorized by the U.S. Food and Drug Administration (FDA) for the prevention of COVID-19 prior to an exposure — which we give to patients with immune-compromising conditions.

December 2, 2021

UPMC clinical leaders announce results of the first ever clinical study comparing methods to administer COVID-19 treatment during a surge in cases, discuss plans to analyze the effectiveness of vaccines and treatments against the Omicron COVID-19 variant, and share safety measures to take during the holiday season.

November 5, 2021

Tami Minnier, Chief Quality Officer, gives an update on how UPMC continues to manage the COVID-19 pandemic. Richard Beigi, MD, president, UPMC Magee-Womens Hospital, discusses the safety of COVID-19 vaccines for pregnant women, and Alejandro Hoberman, MD, president, UPMC Children’s Community Pediatrics, shares the safety data and plans for vaccinating children ages 5 to 11.

UPMC Newsroom

To learn more, visit our UPMC Newsroom.

COVID-19 Information on HealthBeat